Celcuity Inc.
NASDAQ:CELCBiotechnology
Healthcare
$55.60 -4.59%
-$4.04 today
- Market cap
- $2.72B
- Beta
- 0.12
- P/E (TTM)
- -23.7
- EPS (TTM)
- -$3.54
52W Low $11.28High $151.02
Volume 0.98M
Average 1.24M
CELC Pre-Tax Margin
Income before tax as a percentage of revenue.
No reported Pre-Tax Margin figures are available to summarize.
Pre-Tax Margin history
Percent of revenue · from the income statement
No Pre-Tax Margin data reported for this period type.
Pre-Tax Margin vs competitors
How CELC compares with its peers on the latest reported figures
CELC Competitors Peer median
| Company | Period | LTM level | YoY | 3-year change |
|---|---|---|---|---|
BLLNBillionToOne, Inc. | LTM Jun 2026 | 9.5% | +24.1 pp | — |
| LTM Mar 2026 | -5.2% | -4.6 pp | +41.7 pp | |
| LTM Jun 2026 | -7.1% | +8.2 pp | +16.1 pp | |
| LTM Jun 2026 | -20.8% | +38.3 pp | +86.7 pp | |
| LTM Mar 2026 | -148.1% | -50.0 pp | — | |
| FY2025 | — | — | — | |
| Peer median (excluding CELC) | -7.1% | +8.2 pp | +41.7 pp | |
Competitors are the stored peer set for CELC. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Income Statement
USD
Metric | FY2021 Dec 2021 | FY2022 Dec 2022 | FY2023 Dec 2023 | FY2024 Dec 2024 | FY2025 Dec 2025 |
|---|---|---|---|---|---|
| Revenue | 0 | 0 | 0 | 0 | 0 |
| Cost of Revenue | 0 | 0 | 0 | 0 | 167K |
| Gross Profit | 0 | 0 | 0 | 0 | (167K) |
| Gross Margin | — | — | — | — | — |
| Research & Development | 25.76M | 35.29M | 60.59M | 104.2M | 145M |
| Selling, General & Admin | 2.6M | 4.38M | 5.64M | 9.06M | 27.2M |
| Operating Expenses | 28.36M | 39.39M | 66.23M | 113.27M | 172.19M |
| Depreciation & Amortization | 303.24K | 210.92K | 142.77K | 129.95K | 167K |
| EBITDA | (28.04M) | (38.05M) | (58.31M) | (101.37M) | (159.73M) |
| EBITDA Margin | — | — | — | — | — |
| Operating Income | (28.36M) | (39.39M) | (66.23M) | (113.27M) | (172.19M) |
| Operating Margin | — | — | — | — | — |
| Interest Income | 13.26K | 1.13M | 7.78M | 11.77M | 12.3M |
| Interest Expense | 1.26M | 2.11M | 5.33M | 10.28M | 17.15M |
| Other Income / Expenses | (1.25M) | (978.95K) | 2.45M | 1.49M | (4.85M) |
| Income Before Tax | (29.61M) | (40.37M) | (63.78M) | (111.78M) | (177.04M) |
| Pre-Tax Margin | — | — | — | — | — |
| Income Tax Expense | 0 | 0 | 0 | 0 | 0 |
| Net Income | (29.61M) | (40.37M) | (63.78M) | (111.78M) | (177.04M) |
| Net Margin | — | — | — | — | — |
| EPS (Basic) | (2.28) | (2.68) | (2.69) | (2.83) | (3.78) |
| EPS (Diluted) | (2.28) | (2.68) | (2.69) | (2.83) | (3.78) |
| Weighted Avg Shares | 13.38M | 15.42M | 23.68M | 39.45M | 52.54M |
| Weighted Avg Shares (Diluted) | 13.38M | 15.42M | 23.68M | 39.45M | 52.54M |
Celcuity Inc.
NASDAQ:CELC
Intrinsic Alpha fair value
Locked
Current Price
$55.60
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.